Operating EBITDA* grew by 44% to INR 202 crores
Mumbai (Maharashtra), : JB Pharma, one of the fastest growing pharmaceutical companies in India continued on its strong growth momentum, announced its financial results for the second quarter ended 30th September 2022, registering YoY growth of 36% in Q2 FY23 and...